Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study M Fallah, X Liu, J Ji, A Försti, K Sundquist, K Hemminki Annals of Oncology 25 (10), 2025-2030, 2014 | 223 | 2014 |
Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden B Zöller, J Ji, J Sundquist, K Sundquist European Journal of Cancer 48 (12), 1875-1883, 2012 | 208 | 2012 |
Increased risks of coronary heart disease and stroke among spousal caregivers of cancer patients J Ji, B Zöller, K Sundquist, J Sundquist Circulation 125 (14), 1742-1747, 2012 | 170 | 2012 |
Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden B Zöller, J Ji, J Sundquist, K Sundquist European journal of cancer 48 (1), 121-128, 2012 | 166 | 2012 |
Cancer risk among patients hospitalized for type 1 diabetes mellitus: a population‐based cohort study in Sweden X Shu, J Ji, X Li, J Sundquist, K Sundquist, K Hemminki Diabetic medicine 27 (7), 791-797, 2010 | 154 | 2010 |
The Swedish Family‐Cancer Database 2009: prospects for histology‐specific and immigrant studies K Hemminki, J Ji, A Brandt, SM Mousavi, J Sundquist International journal of cancer 126 (10), 2259-2267, 2010 | 139 | 2010 |
An extended Swedish national adoption study of alcohol use disorder KS Kendler, J Ji, AC Edwards, H Ohlsson, J Sundquist, K Sundquist JAMA psychiatry 72 (3), 211-218, 2015 | 138 | 2015 |
Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden J Ji, K Sundquist, Y Ning, KS Kendler, J Sundquist, X Chen Schizophrenia bulletin 39 (3), 527-536, 2013 | 129 | 2013 |
A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma J Ji, K Sundquist, J Sundquist Journal of the National Cancer Institute 104 (10), 790-792, 2012 | 124 | 2012 |
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version) YH Jin, QY Zhan, ZY Peng, XQ Ren, XT Yin, L Cai, YF Yuan, JR Yue, ... Military Medical Research 7, 1-33, 2020 | 112 | 2020 |
Effect of autoimmune diseases on risk and survival in female cancers K Hemminki, X Liu, J Ji, A Försti, J Sundquist, K Sundquist Gynecologic oncology 127 (1), 180-185, 2012 | 111 | 2012 |
Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden J Ji, X Liu, K Sundquist, J Sundquist, K Hemminki Rheumatology 49 (6), 1158-1163, 2010 | 110 | 2010 |
Comparability of cancer identification among death registry, cancer registry and hospital discharge registry J Ji, K Sundquist, J Sundquist, K Hemminki International journal of cancer 131 (9), 2085-2093, 2012 | 108 | 2012 |
The impact of type 2 diabetes mellitus on cancer‐specific survival: a follow‐up study in Sweden X Liu, J Ji, K Sundquist, J Sundquist, K Hemminki Cancer 118 (5), 1353-1361, 2012 | 108 | 2012 |
Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: A national cohort study J Ji, B Zöller, J Sundquist, K Sundquist International Journal of Cancer 139 (4), 754-758, 2016 | 105 | 2016 |
Overexpression of Rac GTPase activating protein 1 contributes to proliferation of cancer cells by reducing hippo signaling to promote cytokinesis XM Yang, XY Cao, P He, J Li, MX Feng, YL Zhang, XL Zhang, YH Wang, ... Gastroenterology 155 (4), 1233-1249. e22, 2018 | 103 | 2018 |
Autoimmune disease and subsequent digestive tract cancer by histology K Hemminki, X Liu, J Ji, J Sundquist, K Sundquist Annals of oncology 23 (4), 927-933, 2012 | 96 | 2012 |
Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden J Ji, X Shu, X Li, K Sundquist, J Sundquist, K Hemminki Annals of oncology 20 (6), 1121-1126, 2009 | 96 | 2009 |
Cancer risk in patients hospitalised for Graves’ disease: a population-based cohort study in Sweden X Shu, J Ji, X Li, J Sundquist, K Sundquist, K Hemminki British journal of cancer 102 (9), 1397-1399, 2010 | 94 | 2010 |
Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study W Huang, J Xiao, J Ji, L Chen Elife 10, e73873, 2021 | 91 | 2021 |